Clinical Trial Update: Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2b study evaluating Taxol plus sorafenib or placebo in advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sorafenib (Sorafenib)
• Taxol (paclitaxel)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN